BANGKOK, Nov. 23 (Xinhua) -- Thailand's National Vaccine Institute on Monday announced that two of seven COVID-19 vaccine candidates have been successfully tested on animals and are moving onto human trials.
The two candidates entering Phase 2 trials on humans are the mRNA vaccine being developed by Chula Vaccine Research Centre (Chula VRC) and the DNA vaccine developed by BioNet-Asia, said Dr. Nakorn Premsri, director of the institute.
Chula VRC expects its mRNA vaccine prototype will enter human trials around April 19 next year.
The mRNA prototype will first be tested on 72 volunteers, and if the tests succeed, the Chula prototype will enter second-phase human trials on 600 people.
Meanwhile, the five other vaccine candidates are all currently being tested on animals, according to Nakorn.
Fire brigade in Shanghai holds group wedding
Tourists enjoy ice sculptures in Datan Town, north China
Sunset scenery of Dayan Pagoda in Xi'an
Tourists have fun at scenic spot in Nanlong Town, NW China
Harbin attracts tourists by making best use of ice in winter
In pics: FIS Alpine Ski Women's World Cup Slalom
Black-necked cranes rest at reservoir in Lhunzhub County, Lhasa
China's FAST telescope will be available to foreign scientists in April
"She power" plays indispensable role in poverty alleviation
Top 10 world news events of People's Daily in 2020
Top 10 China news events of People's Daily in 2020
Top 10 media buzzwords of 2020
Year-ender:10 major tourism stories of 2020
No interference in Venezuelan issues
Biz prepares for trade spat
Broadcasting Continent
Australia wins Chinese CEOs as US loses
